IPO registrations (S-1, F-1) · Registrants
Talecris Biotherapeutics Holdings Corp.
- SEC CIK
- 1405197 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2007-07-27, last 2009-09-28; 1 initial registration, 11 amendments
- Outcome
- Final prospectus filed 2009-10-01; declared effective 2009-09-30
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 4101 RESEARCH COMMONS, 79 T.W. ALEXANDER DRIVE, Research Triangle Park, NC 27709
- EIN
- 20-2533768
- EDGAR entity type
- operating
- Insiders and CEO pay
- Talecris Biotherapeutics Holdings Corp. on the corporate pages
Offering terms
- Final price
- $19.00 per share (424B1 filed 2009-10-01, an initial public offering)
- Shares sold
- 50,000,000 (28,947,368 by the company, 21,052,632 by selling holders)
- Gross proceeds
- $950,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TLCR
- Lead underwriters
- Morgan Stanley (17,500,000 shares); Goldman Sachs (12,500,000 shares)
- Syndicate
- Citigroup (6,500,000); J.P. Morgan (5,000,000); Wells Fargo (4,000,000); Barclays (2,250,000); UBS (2,250,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: GRIFOLS SHARED SERVICES NORTH AMERICA, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: GRIFOLS SHARED SERVICES NORTH AMERICA, INC. EXACT (EIN (EXACT))
- Federal award recipient: TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Fuzzy (name and state)
- SEC filer: Talecris Biotherapeutics Holdings Corp. EXACT (CIK (EXACT))
- Person page: Paul N Clark Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2007-07-27 | S-1 | S-1 (registration) | Talecris Biotherapeutics Holdings Corp. | 0001047469-07-005901 ↗ |
| 2007-09-24 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-07-007171 ↗ |
| 2007-10-19 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-07-007780 ↗ |
| 2007-11-13 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-07-009131 ↗ |
| 2007-12-19 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-07-010180 ↗ |
| 2008-07-23 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-08-008336 ↗ |
| 2009-07-02 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-006624 ↗ |
| 2009-07-21 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-006833 ↗ |
| 2009-08-19 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-007886 ↗ |
| 2009-09-11 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-008277 ↗ |
| 2009-09-21 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-008433 ↗ |
| 2009-09-28 | S-1/A | S-1/A (amendment) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-008564 ↗ |
| 2009-09-30 | S-1MEF | S-1MEF (added securities) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-008669 ↗ |
| 2009-09-30 | EFFECT | EFFECT (declared effective) | Talecris Biotherapeutics Holdings Corp. | 9999999995-09-002709 ↗ |
| 2009-10-01 | 424B1 | 424B1 (final prospectus) | Talecris Biotherapeutics Holdings Corp. | 0001047469-09-008683 ↗ |
| 2010-06-14 | EFFECT | EFFECT (declared effective) | Talecris Biotherapeutics Holdings Corp. | 9999999995-10-001798 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-09-28 | S-1/A | registration statement | 8,000,000 | - | 0 | primary document; shares headline | document ↗ | |||
| 2009-10-01 | 424B1 | final prospectus | $19.00 | 50,000,000 | $950,000,000 | Nasdaq TLCR | 7 | primary document; price sentence, shares headline, proceeds table, underwriting table 7, cover names 7 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Abelson Joel E | Officer | Sr VP & GM, Int'l Bus.; Sr VP & GM, Port & Int. Bus | 9 | 2009–2011 | |
| AMP-01 MANAGEMENT CO LLC | TenPercentOwner | 3 | 2009–2011 | ||
| AMP-99 MANAGEMENT CO LLC | TenPercentOwner | 3 | 2009–2011 | ||
| AMPERSAND 1999 LP | TenPercentOwner | 3 | 2009–2011 | ||
| AMPERSAND 2001 LP | TenPercentOwner | 3 | 2009–2011 | ||
| Auerbach Stuart A | Director | 1 | 2009 | ||
| CHARPIE RICHARD A | Director | 3 | 2009–2011 | ||
| CLARK PAUL N | Director | 4 | 2009–2011 | person page Fuzzy | |
| Engle James R | Officer | Sr. VP, Information Tech.; Sr. VP, Information Technology | 9 | 2009–2011 | |
| FEINBERG STEPHEN | TenPercentOwner | 2 | 2009 | ||
| GAITHER JOHN F JR | Officer | Exec.VP,General Counsel, Secy.; Ex. VP, General Counsel, Secy. | 5 | 2009–2011 | |
| Hanson John M | Officer | Executive VP and CFO; Executive VP & CFO | 5 | 2009–2011 | |
| Heerdt Kari D | Officer | Sr. VP, Human Resources | 6 | 2009–2011 | |
| INGERSOLL W BRETT | Director | 3 | 2009–2011 | ||
| Kuhn Mary J | Officer | Executive VP, Operations | 11 | 2009–2011 | |
| Lenehan James T | Director | 3 | 2009–2011 | ||
| LYNCH THOMAS J | Officer | Sr. VP, Corp. Compliance | 8 | 2009–2011 | |
| MARTIN KENNETH J | Director | 3 | 2009–2011 | ||
| MAYER STEVEN F | Director | 3 | 2009–2011 | ||
| Menichella Daniel L | Officer | Sr. VP, Bus. Development; Sr. VP, Business Development | 7 | 2009–2011 | |
| Nogales Bruce | Officer | Sr VP & GM, Plasma Resources; Sr. VP & GM, Plasma Resources | 9 | 2009–2011 | |
| Perkins John R II | Officer | EVP, Global Commercial; Sr.VP & GM, Portfolio & US Bus; Sr VP & GM, Port. & US Bus. | 7 | 2009–2011 | |
| Petteway Stephen R Jr | Officer | Executive VP, R&D; Ex. VP, Research & Development | 11 | 2009–2011 | |
| Stern Lawrence D | Director,Officer | Chairman and CEO; Chairman & CEO | 6 | 2009–2011 | |
| Waeger Ruedi E | Director | 3 | 2009–2011 | ||
| MITCHELL DEAN J | Director | 4 | 2009–2011 | ||
| Grifols SA | TenPercentOwner | 1 | 2010 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Plan sponsor | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | NC | Federal spending (USAspending) | name and state |
| SEC filer | Talecris Biotherapeutics Holdings Corp. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | GRIFOLS SHARED SERVICES NORTH AMERICA, INC. | EIN (EXACT) | ||
| Person page | Paul N Clark | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Biolex Therapeutics, Inc. NC
- CURAXIS PHARMACEUTICAL Corp NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health